MARLBOROUGH, Mass., April 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of 3.856billionduringthefirstquarterof2024,growing13.8percentonareportedbasis,15.0percentonanoperational1basisand13.1percentonanorganic2basis,allcomparedtotheprioryearperiod.ThecompanyreportedGAAPnetincomeattributabletoBostonScientificcommonstockholdersof495 million or 0.33pershare(EPS),comparedto300 million or $0.21 per share a year ago, ...